Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

KALLIDINOGENASE: 31 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
31
Total FAERS Reports
4 (12.9%)
Deaths Reported
17
Hospitalizations
31
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities

First Report: 201211 · Latest Report: 20250225

What Are the Most Common KALLIDINOGENASE Side Effects?

#1 Most Reported
Drug-induced liver injury
4 reports (12.9%)
#2 Most Reported
Cerebral haemorrhage
4 reports (12.9%)
#3 Most Reported
Urinary retention
3 reports (9.7%)

All KALLIDINOGENASE Side Effects by Frequency

No side effect data available.

Who Reports KALLIDINOGENASE Side Effects? Age & Gender Data

Gender: 20.7% female, 79.3% male. Average age: 68.6 years. Most reports from: JP. View detailed demographics →

Is KALLIDINOGENASE Getting Safer? Reports by Year

YearReportsDeathsHosp.
2012 1 0 1
2013 3 1 1
2014 2 1 1
2015 4 1 2
2016 1 0 1
2017 1 0 0
2018 1 0 1
2020 2 0 0
2021 1 0 1
2022 2 0 1
2023 2 0 1
2024 5 0 3
2025 1 1 1

View full timeline →

What Is KALLIDINOGENASE Used For?

IndicationReports
Product used for unknown indication 10
Cerebral infarction 8

Official FDA Label for KALLIDINOGENASE

Official prescribing information from the FDA-approved drug label.